ciprofloxacin has been researched along with Diabetes Mellitus in 14 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to assess the pharmacokinetic profile of ciprofloxacin in 12 patients with diabetic gastroparesis." | 9.08 | Absorption of ciprofloxacin in patients with diabetic gastroparesis. ( Bassaris, HP; Marangos, MN; Nicolau, DP; Nightingale, CH; Psyrogiannis, AG; Quintiliani, R; Skoutelis, AT; Zhu, Z, 1995) |
| "Forty-eight patients with peripheral vascular disease (46 with diabetes mellitus) who presented to the hospital for treatment of lower extremity infections were randomized in a blinded fashion to receive oral ciprofloxacin at a dosage of either 750 mg or 1,000 mg twice daily." | 9.06 | Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. ( Canter, K; Clabots, C; Fasching, CE; Gerding, DN; Lissack, LM; Peterson, LR, 1989) |
| " Cyclodextrins, via inclusion complexes, increase drug bioavailability and allow an extended release." | 5.56 | Designed sponges based on chitosan and cyclodextrin polymer for a local release of ciprofloxacin in diabetic foot infections. ( Blanchemain, N; Cazaux, F; Chai, F; Foligné, B; Gauzit Amiel, A; Lopez, M; Martel, B; Maton, M; Neut, C; Palomino-Durand, C, 2020) |
| "The purpose of this study was to assess the pharmacokinetic profile of ciprofloxacin in 12 patients with diabetic gastroparesis." | 5.08 | Absorption of ciprofloxacin in patients with diabetic gastroparesis. ( Bassaris, HP; Marangos, MN; Nicolau, DP; Nightingale, CH; Psyrogiannis, AG; Quintiliani, R; Skoutelis, AT; Zhu, Z, 1995) |
| "Forty-eight patients with peripheral vascular disease (46 with diabetes mellitus) who presented to the hospital for treatment of lower extremity infections were randomized in a blinded fashion to receive oral ciprofloxacin at a dosage of either 750 mg or 1,000 mg twice daily." | 5.06 | Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. ( Canter, K; Clabots, C; Fasching, CE; Gerding, DN; Lissack, LM; Peterson, LR, 1989) |
| "In the light of current concerns regarding ciprofloxacin resistance and the changing face of malignant otitis externa, we reviewed cases of malignant otitis externa treated in our centre, in order both to evaluate the current epidemiology of the condition and to assess the status of drug resistance in our patient population." | 3.76 | Malignant otitis externa: case series. ( Ali, T; Anari, S; ElBadawey, MR; Meade, K; Zammit-Maempel, I, 2010) |
| " Cyclodextrins, via inclusion complexes, increase drug bioavailability and allow an extended release." | 1.56 | Designed sponges based on chitosan and cyclodextrin polymer for a local release of ciprofloxacin in diabetic foot infections. ( Blanchemain, N; Cazaux, F; Chai, F; Foligné, B; Gauzit Amiel, A; Lopez, M; Martel, B; Maton, M; Neut, C; Palomino-Durand, C, 2020) |
| "Endogenous endophthalmitis is a rare condition caused by the hematogenous spread of microorganisms from a remote infection site to the eye." | 1.42 | Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis. ( de Haller, R; Mavrakanas, TA; Philippe, J, 2015) |
| "Even extensive malakoplakia can be successfully treated with ciprofloxacin." | 1.30 | [Malacoplakia: a possible complication of poorly controlled diabetes mellitus?]. ( Biesenbach, G; Eichbauer-Sturm, G; Grafinger, P; Höpfl, I; Janko, O; Syré, G, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Koźmiński, P | 1 |
| Gawęda, W | 1 |
| Rzewuska, M | 1 |
| Kopatys, A | 1 |
| Kujda, S | 1 |
| Dudek, MK | 1 |
| Halik, PK | 1 |
| Królicki, L | 1 |
| Gniazdowska, E | 1 |
| Li, JJ | 1 |
| Hu, Y | 1 |
| Hu, B | 1 |
| Wang, W | 1 |
| Xu, H | 1 |
| Hu, XY | 1 |
| Ding, F | 1 |
| Li, HB | 1 |
| Wang, KR | 1 |
| Zhang, X | 1 |
| Guo, DS | 1 |
| Taki, E | 1 |
| Jabalameli, F | 1 |
| Mohajeri Tehrani, MR | 1 |
| Feizabadi, MM | 1 |
| Beigverdi, R | 1 |
| Emaneini, M | 1 |
| Gauzit Amiel, A | 1 |
| Palomino-Durand, C | 1 |
| Maton, M | 1 |
| Lopez, M | 1 |
| Cazaux, F | 1 |
| Chai, F | 1 |
| Neut, C | 1 |
| Foligné, B | 1 |
| Martel, B | 1 |
| Blanchemain, N | 1 |
| Saad, NA | 1 |
| Elberry, AA | 1 |
| Samy Matar, H | 1 |
| Hussein, RRS | 1 |
| Mavrakanas, TA | 1 |
| de Haller, R | 1 |
| Philippe, J | 1 |
| Boeri, L | 1 |
| Fontana, M | 1 |
| Gallioli, A | 1 |
| Zanetti, SP | 1 |
| Catellani, M | 1 |
| Longo, F | 1 |
| Mangiarotti, B | 1 |
| Montanari, E | 1 |
| Ali, T | 1 |
| Meade, K | 1 |
| Anari, S | 1 |
| ElBadawey, MR | 1 |
| Zammit-Maempel, I | 1 |
| Agrawal, M | 1 |
| Bhardwaj, V | 1 |
| Tsering, W | 1 |
| Sural, S | 1 |
| Kashyap, R | 1 |
| Dhal, A | 1 |
| Dignass, AU | 1 |
| Herrlinger, K | 1 |
| Schölmerich, J | 1 |
| Maskin, SL | 1 |
| Marangos, MN | 1 |
| Skoutelis, AT | 1 |
| Nightingale, CH | 1 |
| Zhu, Z | 1 |
| Psyrogiannis, AG | 1 |
| Nicolau, DP | 1 |
| Bassaris, HP | 1 |
| Quintiliani, R | 1 |
| Eichbauer-Sturm, G | 1 |
| Janko, O | 1 |
| Grafinger, P | 1 |
| Höpfl, I | 1 |
| Syré, G | 1 |
| Biesenbach, G | 1 |
| Peterson, LR | 1 |
| Lissack, LM | 1 |
| Canter, K | 1 |
| Fasching, CE | 1 |
| Clabots, C | 1 |
| Gerding, DN | 1 |
3 trials available for ciprofloxacin and Diabetes Mellitus
| Article | Year |
|---|---|
Effect of ciprofloxacin vs levofloxacin on QTc-interval and dysglycemia in diabetic and non-diabetic patients.
Topics: Adult; Ciprofloxacin; Diabetes Mellitus; Fluoroquinolones; Humans; Levofloxacin; Prospective Studies | 2021 |
Absorption of ciprofloxacin in patients with diabetic gastroparesis.
Topics: Adult; Aged; Biological Availability; Ciprofloxacin; Diabetes Complications; Diabetes Mellitus; Fema | 1995 |
Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both.
Topics: Adult; Bacteria; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Diabetes Complicatio | 1989 |
11 other studies available for ciprofloxacin and Diabetes Mellitus
| Article | Year |
|---|---|
Physicochemical and Biological Study of
Topics: Ciprofloxacin; Diabetes Mellitus; Diabetic Foot; Gallium Radioisotopes; Humans; Radiopharmaceuticals | 2021 |
Lactose azocalixarene drug delivery system for the treatment of multidrug-resistant pseudomonas aeruginosa infected diabetic ulcer.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Ciprofloxacin; Delayed-Action Preparations; | 2022 |
Microbial Profile and Antibiotic Susceptibility Pattern in Diabetic Patients with Mild, Moderate, and Severe Foot Infections in Tehran.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellitus; Diabetic Fo | 2022 |
Designed sponges based on chitosan and cyclodextrin polymer for a local release of ciprofloxacin in diabetic foot infections.
Topics: Anti-Bacterial Agents; Cellulose; Chitosan; Ciprofloxacin; Cyclodextrins; Diabetes Mellitus; Diabeti | 2020 |
Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Complications; Diabetes Mellitus; Endophthalmit | 2015 |
Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxaci | 2017 |
Malignant otitis externa: case series.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Cranial Nerve Diseases; Diabetes Mell | 2010 |
Use of technetium(99m)-ciprofloxacin scan in Pott's spine to assess the disease activity.
Topics: Adult; Aged; Ciprofloxacin; Comorbidity; Diabetes Mellitus; Female; Humans; Magnetic Resonance Imagi | 2012 |
[Ulcerative colitis. Chronic active course].
Topics: Administration, Oral; Adult; Age Factors; Anti-Infective Agents; Azathioprine; Child; Chronic Diseas | 2004 |
Infectious scleritis after a diabetic foot ulcer.
Topics: Administration, Oral; Administration, Topical; Ciprofloxacin; Diabetes Mellitus; Drug Therapy, Combi | 1993 |
[Malacoplakia: a possible complication of poorly controlled diabetes mellitus?].
Topics: Abdomen; Anti-Infective Agents; Biopsy; Ciprofloxacin; Diabetes Complications; Diabetes Mellitus; Fe | 1999 |